Document is current
Any future updates will be listed below
-
Authors
Sugimoto, Mitsushige https://orcid.org/0000-0002-9194-7392
Kamada, Tomoari
Ito, Masanori
Iwamoto, Junichi
Okimoto, Tadayoshi
Ono, Shoko
Kanno, Takeshi
Chiba, Toshimi
Tokunaga, Kengo
Nomura, Sachiyo
Murao, Takahisa
Watanabe, Toshio
Asaoka, Daisuke
Iwata, Eri
Wang, Ting
Ono, Hideki
Katsumata, Ryo
Kikuchi, Satoshi
Konishi, Naoki
Sato, Satoshi
Sunago, Aya
Sekiguchi, Hiromi
Cho, Hourin
Chinda, Daisuke
Dohi, Osamu
Nakata, Akinobu
Higashimori, Akira
Hirashita, Yuka
Misawa, Keigo
Mizukami, Kazuhiro
Miyamori, Daisuke
Mukohyama, Junko
Mori, Hideki
Yoshida, Shuhei
Watanabe, Jun
Satoh, Kiichi
Mizokami, Yuji
Takagi, Atsushi
Takeyama, Yoshifumi
Eguchi, Susumu
Watanabe, Sumio
Isomoto, Hajime
Itoi, Takao
Mochida, Satoshi
- License Information
-
More Information
Article History
Received: 13 July 2026
Accepted: 12 August 2026
First Online: 24 August 2026
Declarations
Conflict of interest: Any financial relationship with enterprises, businesses, or academic institutions in the subject matter or materials discussed in the manuscript is listed as follows: (1) personal remuneration (honoraria, consulting fees, advisory roles, etc.) AbbVie Inc.; AstraZeneca K.K.; ASKA Pharmaceutical Co., Ltd.; Chugai Pharmaceutical Co., Ltd.; EA Pharma; Eisai Co., Ltd.; Gilead Sciences Co., Ltd.; Otsuka Pharmaceutical Co., Ltd.; Toray Industries Inc,. (2) institutional research funding or other support (commercial/academic cooperation). Nobel pharma Co., Ltd.
Ethical approval: Not applicable.
Consent to participate: Not applicable.
Consent for publication: Not applicable.
